Management of Bradycardia in Patients with Head Injuries
Bradycardia in head injury patients should be managed with a stepwise approach starting with identification and treatment of the underlying cause, ensuring adequate oxygenation, and using pharmacologic therapy or temporary pacing for symptomatic cases. 1
Pathophysiology and Recognition
- Bradycardia in head injury patients often occurs due to the Cushing reflex, characterized by hypertension, bradycardia, and apnea secondary to increased intracranial pressure (ICP) 2
- Bradycardia may also result from direct brainstem compression, autonomic dysregulation, or as part of a vago-vagal reflex, especially during procedures like tracheal suctioning 3
- Multiple types of arrhythmias can occur in head injury patients, with bradycardia being among the most common 4, 5
- ECG changes after head trauma can include bradycardia, shortening of Q-Tc interval, prolongation of Q-T interval, and rhythm alterations, lasting from seconds to hours 6
Initial Assessment and Management
Identify and treat the underlying cause 1
- Assess for increased intracranial pressure
- Evaluate for hypoxemia, which is a common cause of bradycardia
Maintain patent airway and assist breathing as necessary 1
- Ensure adequate oxygenation, as hypoxemia can worsen bradycardia
- Provide supplementary oxygen if oxygenation is inadequate or if the patient shows signs of increased work of breathing
Monitor vital signs and obtain diagnostic information 1
- Attach cardiac monitor to identify rhythm
- Monitor blood pressure and oxygen saturation
- Establish IV access
- Obtain 12-lead ECG if available (without delaying therapy)
Pharmacologic Management
Atropine is the first-line drug for acute symptomatic bradycardia (Class IIa, LOE B) 1, 7
- Dosage: 0.5 to 1 mg IV, repeated every 3-5 minutes as needed up to a total of 1.5 to 3 mg
- Mechanism: Atropine abolishes various types of reflex vagal cardiac slowing or asystole by blocking parasympathetic activity 7
- Caution: Atropine may be ineffective in heart transplant patients due to denervation 1
Second-line agents for bradycardia unresponsive to atropine: 1
- Epinephrine (2 to 10 μg/min) or
- Dopamine (2 to 10 μg/kg/min)
For specific situations:
Temporary Pacing
Temporary transvenous pacing is reasonable for patients with persistent hemodynamically unstable bradycardia refractory to medical therapy (Class IIa, LOE C-LD) 1
- Indicated until permanent pacemaker is placed or bradycardia resolves
Temporary transcutaneous pacing may be considered in patients with severe symptoms or hemodynamic compromise (Class IIb, LOE C-LD) 1
- Used as a bridge until transvenous pacing can be established or bradycardia resolves
Avoid temporary pacing in patients with minimal or infrequent symptoms without hemodynamic compromise (Class III: Harm, LOE C-LD) 1
Special Considerations for Head Injury Patients
- Ensure transfer to a specialized center with neurosurgical facilities for severe traumatic brain injury patients 1
- During procedures like tracheal suctioning in patients with high cervical spinal cord injuries, ensure adequate oxygenation to prevent reflex bradycardia 3
- Consider prophylactic atropine before procedures known to trigger bradycardia in susceptible patients 3
- Monitor for other cardiac arrhythmias that may occur with head injuries, as multiple types can be present 4, 5
Potential Complications and Pitfalls
- Bradycardia may be a warning sign of increasing intracranial pressure and should prompt neurological reassessment 2
- Temporary transvenous pacing carries risks including venous thrombosis, pulmonary emboli, life-threatening arrhythmias, and infection 1
- Atropine may paradoxically cause high-degree AV block in patients after cardiac transplantation 1
- In patients with complete heart block, atropine may accelerate idioventricular rate in some patients but cause AV block and nodal rhythm in others 7